Gain Therapeutics (GANX) PT Raised to $10 at Roth/MKM
Tweet Send to a Friend
(Updated - December 22, 2025 8:53 AM EST)
Roth/MKM analyst Boobalan Pachaiyappan raised the price target on Gain ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth/MKM analyst Boobalan Pachaiyappan raised the price target on Gain ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
